EndoChoice CFO buys 5k shares of the company: 4 points

David N. Gill, CFO of EndoChoice, purchased 5,000 shares of the company in a recent transaction, according to the SCSU Collegian.

Advertisement

Here are four points:

1. The shares were purchased at $4.77 per share for a total value of $23,850.

2. Institutional Investors own 47.89 percent of EndoChoice Holdings’ shares.

3. The 52-week high of the company’s share price is $19.68 and the 52-week low is $3.70.

4. The company has a market cap of $117 million.

More articles on GI/endoscopy:
GI physician leader to know: Dr. Neena Abraham of Mayo Clinic
5 most read GI/endoscopy stories: Week of Feb. 29 – March 4
St. Francis Regional, Ridgeview medical centers come together for GI care: 4 things to know

Advertisement

Next Up in GI & Endoscopy

  • Gastroenterologists are raising concerns about the CMS’ finalized payment policies, according to a joint statement from the American College of…

  • As gastroenterology evolves, leaders are reimagining how to deliver comprehensive, patient-centered care.  Dinesh Madhok, MD, CEO of Jacksonville, Fla.-based Borland…

  • The FDA has approved linaclotide (Linzess) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation,…

Advertisement

Comments are closed.